238 related articles for article (PubMed ID: 20428771)
1. BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells.
Huang YT; Lai PC; Wu CC; Hsu SH; Cheng CC; Lan YF; Chiu TH
Int J Oncol; 2010 Jun; 36(6):1469-76. PubMed ID: 20428771
[TBL] [Abstract][Full Text] [Related]
2. TrkB antibody elicits cytotoxicity and suppresses migration/invasion of transitional cell carcinoma cells.
Huang YT; Lai PC; Wu CC; Cheng CC; Chiu TH
Int J Oncol; 2010 Oct; 37(4):943-9. PubMed ID: 20811716
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of BDNF and TrkB in human bladder cancer specimens.
Lai PC; Chiu TH; Huang YT
Oncol Rep; 2010 Nov; 24(5):1265-70. PubMed ID: 20878119
[TBL] [Abstract][Full Text] [Related]
4. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
[TBL] [Abstract][Full Text] [Related]
5. Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer.
Yuan Y; Ye HQ; Ren QC
Oncol Rep; 2018 Aug; 40(2):621-634. PubMed ID: 29989647
[TBL] [Abstract][Full Text] [Related]
6. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
[TBL] [Abstract][Full Text] [Related]
7. MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer.
Gao L; Yan P; Guo FF; Liu HJ; Zhao ZF
Neoplasma; 2018; 65(1):89-96. PubMed ID: 29322793
[TBL] [Abstract][Full Text] [Related]
8. Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival.
Akil H; Perraud A; Mélin C; Jauberteau MO; Mathonnet M
PLoS One; 2011; 6(9):e25097. PubMed ID: 21966426
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.
Vanhecke E; Adriaenssens E; Verbeke S; Meignan S; Germain E; Berteaux N; Nurcombe V; Le Bourhis X; Hondermarck H
Clin Cancer Res; 2011 Apr; 17(7):1741-52. PubMed ID: 21350004
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of brain-derived neurotrophic factor/tyrosine kinase B signaling suppresses choriocarcinoma cell growth.
Kawamura N; Kawamura K; Manabe M; Tanaka T
Endocrinology; 2010 Jul; 151(7):3006-14. PubMed ID: 20463055
[TBL] [Abstract][Full Text] [Related]
11. A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma.
Lee J; Jiffar T; Kupferman ME
PLoS One; 2012; 7(1):e30246. PubMed ID: 22276165
[TBL] [Abstract][Full Text] [Related]
12. BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer.
Brunetto de Farias C; Rosemberg DB; Heinen TE; Koehler-Santos P; Abujamra AL; Kapczinski F; Brunetto AL; Ashton-Prolla P; Meurer L; Reis Bogo M; Damin DC; Schwartsmann G; Roesler R
Oncology; 2010; 79(5-6):430-9. PubMed ID: 21474968
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer.
Okugawa Y; Tanaka K; Inoue Y; Kawamura M; Kawamoto A; Hiro J; Saigusa S; Toiyama Y; Ohi M; Uchida K; Mohri Y; Kusunoki M
Br J Cancer; 2013 Jan; 108(1):121-30. PubMed ID: 23175149
[TBL] [Abstract][Full Text] [Related]
14. The secreted brain-derived neurotrophic factor precursor pro-BDNF binds to TrkB and p75NTR but not to TrkA or TrkC.
Fayard B; Loeffler S; Weis J; Vögelin E; Krüttgen A
J Neurosci Res; 2005 Apr; 80(1):18-28. PubMed ID: 15704182
[TBL] [Abstract][Full Text] [Related]
15. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer.
Yu X; Liu L; Cai B; He Y; Wan X
Cancer Sci; 2008 Mar; 99(3):543-52. PubMed ID: 18201274
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of brain-derived neurotrophic factors and receptors in multiple myeloma].
Sun CY; Hu Y; Wu T; Wang YD; He WJ
Zhonghua Nei Ke Za Zhi; 2005 Dec; 44(12):906-9. PubMed ID: 16409727
[TBL] [Abstract][Full Text] [Related]
17. Brain-Derived Neurotrophic Factor Regulates Ishikawa Cell Proliferation through the TrkB-ERK1/2 Signaling Pathway.
Cao M; Niu Q; Xiang X; Yuan C; Iqbal T; Huang Y; Tian M; Zhao Z; Li C; Zhou X
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33302387
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
[TBL] [Abstract][Full Text] [Related]
19. Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.
Ping SY; Wu CL; Yu DS
Urol Oncol; 2012 Sep; 30(5):652-9. PubMed ID: 20884251
[TBL] [Abstract][Full Text] [Related]
20. Suppression of hydatidiform molar growth by inhibiting endogenous brain-derived neurotrophic factor/tyrosine kinase B signaling.
Kawamura K; Kawamura N; Kawagoe Y; Kumagai J; Fujimoto T; Terada Y
Endocrinology; 2012 Aug; 153(8):3972-81. PubMed ID: 22719055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
